3328 A randomized controlled phase II clinical trial on autologous monocyte-derived mRNA electroporated dendritic cells for stage III/IV melanoma patients who are disease-free following the local treatment of macrometastases. (September 2015) - Jansen, Y.; Corthals, J.; Wilgenhof, S.; Schreuer, M.; Heirman, C.; Thielemans, K.; Neyns, B.